Urinary D‐glucaric acid excretion during rifampicin/isoniazid and anticonvulsant enzyme induction

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Clinical pharmacology and therapy

• Publication date

  1984-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/clpt.1984.99PMID 6143635
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin

  1979cited by this paper
• Elevation of plasma levels of lysosomal enzymes during treatment with rifampicin and isoniazid.

  1978cited by this paper
• Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.

  1977cited by this paper
• Letter: Induction of hepatic cortisol-6-hydroxylase by rifampicin.

  1976cited by this paper
• Letter: Induction of hepatic cortisol-6-hydroxylase by rifampicin.

  1976cited by this paper
• Glucaric acid as an indicator of use of enzyme‐inducing drugs

  1974cited by this paper
• Urinary D-glucaric acid assay by an improved enzymatic procedure.

  1974cited by this paper
• Osteomalacia after Prolonged Glutethimide Administration

  1973cited by this paper
• Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man.

  1971cited by this paper
• The fluorimetric estimation of β-glucuronidase in blood plasma

  1965cited by this paper
• Serum Glutamic Pyruvic Transaminase in Cardiac and Hepatic Disease.∗

  1956cited by this paper

• A single and multiple dose bioavailability study with carbamazepine 400 mg retard tablets with reference to enzyme autoinduction and circadian time differences.

  1997cites this paper
• Rifampicin, halothane and glucose as mediators of lysosomal enzyme release and tissue damage.

  1988cites this paper
• Plasma gamma glutamyltransferase levels during rifampicin therapy for tuberculosis.

  1987cites this paper
• [Possibilities of evaluating the activity of the drug biotransformation system in clinical pharmacology].

  1987cites this paper
• [Metabolism of rifampicin in the human body (2nd report)--Initial change of the rifampicin metabolism, its glucuronidation and its enzymatic oxidation in the stomach].

  1987cites this paper
• D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy.

  1986cites this paper
• Hepatic mixed function oxidase induction during rifampicin/isoniazid therapy in Indian vegetarians.

  1986cites this paper
• Note on the enzyme assay for urinary D-glucaric acid and correlation with rifampicin-induced mixed function oxidase activity.

  1986cites this paper